Amryt Pharma plc (LON:AMYT – Get Free Report) shares crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 143 ($1.78) and traded as low as GBX 143 ($1.78). Amryt Pharma shares last traded at GBX 143 ($1.78), with a volume of 90,727 shares.
Amryt Pharma Price Performance
The company has a market capitalization of £457.11 million and a PE ratio of -4.33. The firm has a fifty day moving average of GBX 143 and a two-hundred day moving average of GBX 143. The company has a current ratio of 1.80, a quick ratio of 1.14 and a debt-to-equity ratio of 66.05.
About Amryt Pharma
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Featured Articles
- Five stocks we like better than Amryt Pharma
- Trading Halts Explained
- Comprehensive PepsiCo Stock Analysis
- What Does Downgrade Mean in Investing?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Dividend Capture Strategy: What You Need to Know
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
